We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IMMX market cap is 39.93M. The company's latest EPS is USD -0.7765 and P/E is -2.59.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.52M | -3.72M | -4.52M | -5.38M | -5.59M |
| Net Income | -2.48M | -3.58M | -4.28M | -5.09M | -5.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -842k | -454k | -1.35M | -8.22M | -16.14M |
| Net Income | -973k | -1.15M | -24.38M | -8.23M | -15.43M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.21M | 15.57M | 22.48M | 19.93M | 34.35M |
| Total Liabilities | 1.47M | 2.4M | 2.83M | 3.72M | 6.72M |
| Total Equity | 11.74M | 13.17M | 19.65M | 16.2M | 27.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 943k | 540k | 18.19M | 14.91M | 19.93M |
| Total Liabilities | 4.59M | 5.27M | 202k | 1.75M | 3.72M |
| Total Equity | -3.65M | -4.73M | 17.99M | 13.16M | 16.2M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.09M | -5.61M | -8.69M | -11.37M | -3.83M |
| Investing | N/A | N/A | -39k | -52k | -302k |
| Financing | 119k | 4.81M | 14.88M | 15.46M | 15.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -790k | -405k | -1.59M | -7.41M | -11.37M |
| Investing | -7k | N/A | -1,000 | N/A | -52k |
| Financing | 1.05M | N/A | 18.85M | 3.23M | 15.46M |
| Market Cap | 39.93M |
| Price to Earnings Ratio | -2.59 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.28 |
| Price to Book Ratio | 2.46 |
| Dividend Yield | - |
| Shares Outstanding | 19.87M |
| Average Volume (1 week) | 137.39k |
| Average Volume (1 Month) | 116.29k |
| 52 Week Change | -11.84% |
| 52 Week High | 7.75 |
| 52 Week Low | 1.55 |
| Spread (Intraday) | 0.44 (19.64%) |
| Company Name | Immix Biopharma Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://immixbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
